Kok H Petra, Herrera Timoteo D, Crezee Johannes
Amsterdam UMC Location University of Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Treatment and Quality of Life, Cancer Biology and Immunology, Amsterdam, The Netherlands.
Amsterdam UMC Location University of Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Treatment and Quality of Life, Cancer Biology and Immunology, Amsterdam, The Netherlands.
Int J Radiat Oncol Biol Phys. 2023 Mar 15;115(4):994-1003. doi: 10.1016/j.ijrobp.2022.10.023. Epub 2022 Oct 23.
The radiosensitization effect of hyperthermia can be considered and quantified as an enhanced equivalent radiation dose (EQD), that is, the dose needed to achieve the same effect without hyperthermia. EQD can be predicted using an extended linear quadratic model, with temperature-dependent parameters. Clinical data show that both the achieved temperature and time interval between radiation therapy and hyperthermia correlate with clinical outcome, but their effect on expected EQD is unknown and was therefore evaluated in this study.
Biological modeling was performed using our in-house developed software (X-Term), considering a 23- × 2-Gy external beam radiation scheme, as applied for patients with locally advanced cervical cancer. First, the EQD was calculated for homogeneous temperature levels, evaluating time intervals between 0 and 4 hours. Next, realistic heterogeneous hyperthermia treatment plans were combined with radiation therapy plans and the EQD was calculated for 10 patients. Furthermore, the effect of achieving 0.5°C to 1°C lower or higher temperatures was evaluated.
EQD increases substantially with both increasing temperature and decreasing time interval. The effect of the time interval is most pronounced at higher temperatures (>41°C). At a typical hyperthermic temperature level of 41.5°C, an enhancement of ∼10 Gy can be realized with a 0-hour time interval, which is decreased to only ∼4 Gy enhancement with a 4-hour time interval. Most enhancement is already lost after 1 hour. Evaluation in patients predicted an average additional EQD (D95%) of 2.2 and 6.3 Gy for 4- and 0-hour time intervals, respectively. The effect of 0.5°C to 1°C lower or higher temperatures is most pronounced at high temperature levels and short time intervals. The additional EQD (D95%) ranged between 1.5 and 3.3 Gy and between 4.5 and 8.5 Gy for 4- and 0-hour time intervals, respectively.
Biological modeling provides relevant insight into the relationship between treatment parameters and expected EQD. Both high temperatures and short time intervals are essential to maximize EQD.
热疗的放射增敏效应可被视为并量化为增强等效辐射剂量(EQD),即无热疗时达到相同效果所需的剂量。EQD可使用扩展线性二次模型预测,其参数与温度有关。临床数据表明,达到的温度以及放射治疗与热疗之间的时间间隔均与临床结果相关,但它们对预期EQD的影响尚不清楚,因此本研究对其进行了评估。
使用我们自行开发的软件(X-Term)进行生物学建模,考虑用于局部晚期宫颈癌患者的23×2-Gy外照射方案。首先,针对均匀温度水平计算EQD,评估0至4小时的时间间隔。接下来,将实际的非均匀热疗治疗计划与放射治疗计划相结合,并为10名患者计算EQD。此外,评估了温度降低或升高0.5°C至1°C的影响。
EQD随温度升高和时间间隔缩短而显著增加。时间间隔的影响在较高温度(>41°C)时最为明显。在典型的热疗温度水平41.5°C下,时间间隔为0小时时可实现约10 Gy的增强,时间间隔为4小时时增强仅降至约4 Gy。1小时后大部分增强效果已经丧失。对患者的评估预测,时间间隔为4小时和0小时时,平均额外EQD(D95%)分别为2.2 Gy和6.3 Gy。温度降低或升高0.5°C至1°C的影响在高温水平和短时间间隔时最为明显。时间间隔为4小时和0小时时,额外EQD(D95%)分别在1.5至3.3 Gy和4.5至8.5 Gy之间。
生物学建模为治疗参数与预期EQD之间的关系提供了相关见解。高温和短时间间隔对于使EQD最大化至关重要。